Mayo Clinic breast cancer

First U.S. Patient Receives Novel Radioactive Breast Cancer Treatment at Mayo Clinic

Mayo Clinic shared a post on LinkedIn:

“Mayo Clinic has treated the first person in the U.S. using a novel radioactive medicine for advanced breast cancer as part of an international multisite clinical trial.⁠

The principal investigator at Mayo Clinic is Geoffrey Johnson, M.D., Ph.D., a professor of radiology and a leader in radiopharmaceutical therapies. He says these are innovative cancer treatments that use radioactive medicines designed to target and kill cancer cells with high precision.⁠”

First U.S. Patient Receives Novel Radioactive Breast Cancer Treatment at Mayo Clinic

More Posts Featuring Mayo Clinic.

Breast Cancer cancer Geoffrey Johnson Mayo Clinic OncoDaily Oncology